Angeles City logs record-high COVID-19 recoveries at 334 | Inquirer News

Angeles City logs record-high COVID-19 recoveries at 334

/ 01:32 PM September 30, 2021

Angeles City

Angeles City starts to get relief from the COVID-19 surge as active cases continue to go down. (Photo by Jun A. Malig)

ANGELES CITY––The city government recorded Wednesday 334 COVID-19 recoveries, its all-time high since the pandemic struck last year.

The figure brought down the active cases to 967 from 1,441 on Sept. 24. It reflected a 32-percent drop in the last five days, data showed.

Article continues after this advertisement

Most of the new recoveries are residents of Cutcut village (104), Sto. Domingo (52), and Anunas (38).

FEATURED STORIES

Only 33 new cases and zero COVID-19 related fatalities were also registered on Wednesday.

Cutcut still has the most active cases at 84, followed by Tabun with 69, and the biggest village of Balibago with 63.

Article continues after this advertisement

This city has recorded 11,807 COVID-19 cases since the pandemic began last year. Of these, 10,366 have recovered, while 474 have died.

Article continues after this advertisement

As of Sept. 23, the city government has fully inoculated 143,969 residents here against COVID-19. Some 161,924 individuals have also received their first dose of the vaccines.

It aims to vaccinate about 324,000 city residents.

lzb
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Angeles City, Regions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.